ivosidenib,azacitidine
servier
['myeloid', 'leukemia', 'tibsovo', 'aza ', 'vidaza']
tibsovo plus vidaza improved survival and event-free survival in certain patients with acute myeloid leukemia, according to study results presented at #asco22 
Cancer updates, research and education for patients with cancer, survivors and their caregivers to become empowered advocates in their journey.